F2Gor Functional Fungal Genomicsis A Clinical Stage Biopharmaceutical Company Based In Manchesterunited Kingdomfounded In 1998F2G Specializes In Discovering And Developing Innovative Antifungal Drugs Aimed At Treating Rare And Life Threatening Fungal Infectionsthe Company Utilizes Its Proprietary Genomics Technologymycobankto Identify Essential Gene Targets In Fungienabling The Development Of Targeted Therapies One Of F2G S Key Products Is Olorofima Novel Antifungal Drug Candidate Currently In Late Stage Developmentthis Drug Is Designed To Address Serious Fungal Diseases That Have Limited Treatment Optionsf2G Is Committed To Improving Patient Outcomes By Providing Healthcare Providers And Patients With New Treatment Options That Enhance Survival And Quality Of Lifethe Company Has Secured Significant Funding To Support The Advancement Of Olorofim And Its Mission To Bring Innovative Antifungal Treatments To Market
No conferences found for this company.
| Company Name | F2g Ltd |
| Country |
United Kingdom
|
| Address | N/A |
| Telephone | N/A |
| N/A |
